C. Purpose of this guidance:
• To outline the practical arrangements for notification.
• To provide advice on what should and what should not be classified as a “serious breach” and what must be reported.
• To outline possible actions that may be taken by the MHRA in response to notifications of serious breaches.
Current clinical trials
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Active, not recruiting
Completed